Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Yu

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2025
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung CancerJessica S Ross, Rohit Thummalapalli, Christopher A Febres-Aldana, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Acta Neuropathologica Communications|September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumorsRichard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLCAmin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.
Nature|April 16, 2025
An ultrasensitive method for detection of cell-free RNAMonica C Nesselbush, Bogdan A Luca, Young-Jun Jeon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort StudyAmin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.
Nature|November 7, 2024
Automated real-world data integration improves cancer outcome predictionJustin Jee, Christopher Fong, Karl Pichotta, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2025
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung CancerJessica S Ross, Rohit Thummalapalli, Christopher A Febres-Aldana, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Acta Neuropathologica Communications|September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumorsRichard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2024
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLCAmin H Nassar, Ritujith Jayakrishnan, Jamie Feng, et al.
Nature|April 16, 2025
An ultrasensitive method for detection of cell-free RNAMonica C Nesselbush, Bogdan A Luca, Young-Jun Jeon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2024
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort StudyAmin H Nassar, So Yeon Kim, Jacqueline V Aredo, et al.
Nature|November 7, 2024
Automated real-world data integration improves cancer outcome predictionJustin Jee, Christopher Fong, Karl Pichotta, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 4